S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.46
+1.78
+10.67%
NEPH · Nephros, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$3.58
+0.04
(+1.27%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$3.58
$3.58
$3.58
52-WEEK RANGE
$3.58
$2.66
$6.42
What's happening
- NEPH is up 1.27% today, trading at $3.58. — Live quote
- Volume today (186) is well below its 3-month average of 24,400. (Finnhub fundamentals)
- Reports earnings on 2026-11-04, 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.11 actual vs. $0.00 estimated (+3448.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 5
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
NEPH
-25.20%
vs S&P 500
-37.13%
1-YEAR RETURN
NEPH
-31.52%
vs S&P 500
-47.05%
6-MONTH RETURN
NEPH
+26.74%
3-MONTH RETURN
NEPH
-3.44%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.11
Est. $0.00
BEAT +3448.4%
2026-04-26 (Q1 2026)
$0.01
Est. $0.01
MISS -2.0%
2026-01-26 (Q4 2025)
$0.08
Est. $0.01
BEAT +684.3%
2025-10-26 (Q3 2025)
$0.03
Est. $-0.02
BEAT +247.1%
Valuation Measures & Ratios
Enterprise Value4$35.0M
Forward P/E518.40
PEG Ratio60.89
Price / Sales (TTM1)1.91
Price / Book73.24
EV4 / Revenue1.69
EV4 / EBITDA19.46
Profit Margin8.38%
Operating Margin7.92%
Return on Equity (ROE8)16.20%
Return on Assets (ROA9)12.30%
Avg Volume (3M)24,400
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $39.0M | $41.7M | $52.3M | $48.2M | $18.6M |
| P/E | 20.39 | 32.80 | 39.81 | 70.00 | 65.86 |
| Price/Sales | 1.91 | 2.16 | 2.98 | 3.00 | 1.23 |
| EV/Revenue | 1.68 | 1.96 | 2.68 | 2.69 | 0.96 |
| ROA | 12.12% | 9.22% | 9.93% | 5.63% | 2.40% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short25,302
Change from Prior Settlement-45.47%
% of Float—
Days to Cover (Short Ratio)1.38
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 36.2% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-13; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 8.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -31.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on NEPH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0M | $5.2M | $4.8M | $4.4M | $4.9M | $3.5M | $3.3M | $3.5M |
| Gross profit | $4.0M | $3.0M | $2.9M | $2.8M | $3.2M | $2.1M | $1.9M | $2.2M |
| Operating income | $1.2M | $97.0K | $314.0K | $248.0K | $566.0K | $206.0K | -$317.0K | -$200.0K |
| Net income | $1.2M | $140.0K | $337.0K | $237.0K | $558.0K | $183.0K | -$289.0K | -$169.0K |
| EPS (diluted) | $0.11 | $0.01 | $0.03 | $0.02 | $0.05 | $0.02 | $-0.03 | $-0.02 |
| EPS (basic) | $0.11 | $0.01 | $0.03 | $0.02 | $0.05 | $0.02 | $-0.03 | $-0.02 |
| Operating margin | $20 | $2 | $7 | $6 | $12 | $6 | -$10 | -$6 |
| Net margin | $20 | $3 | $7 | $5 | $11 | $5 | -$9 | -$5 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $15.8M | $13.8M | $13.6M | $13.2M | $12.2M | $11.8M | $11.2M | $10.4M |
| Total liabilities | $3.8M | $3.1M | $3.4M | $3.2M | $2.6M | $2.5M | $2.6M | $2.2M |
| Stockholders' equity | — | — | — | — | — | — | — | — |
| Total current assets | $13.6M | $11.5M | $11.2M | $10.7M | $9.6M | $9.0M | $8.3M | $7.4M |
| Total current liabilities | $3.3M | $2.5M | $2.8M | $2.5M | $1.8M | $1.5M | $1.6M | $1.1M |
| Cash & equivalents | $4.7M | $4.0M | $5.4M | $5.2M | $5.1M | $4.1M | $3.8M | $2.5M |
| Accounts receivable | $4.1M | $3.5M | $2.4M | $2.7M | $2.0M | $2.7M | $1.8M | $1.7M |
| Inventory | $4.5M | $3.6M | $3.2M | $2.7M | $2.2M | $2.0M | $2.6M | $3.1M |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $83.0K | $95.0K | $106.0K | $119.0K | $131.0K | $143.0K | $161.0K | $173.0K |
| Goodwill | $759.0K | $759.0K | $759.0K | $759.0K | $759.0K | $759.0K | $759.0K | $759.0K |
| Intangible assets | $302.0K | $310.0K | $318.0K | $326.0K | $334.0K | $341.0K | $349.0K | $357.0K |
| Other non-current assets | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K |
| Accounts payable | $2.0M | $1.5M | $914.0K | $936.0K | $632.0K | $557.0K | $649.0K | $398.0K |
| Accrued liabilities | $965.0K | $662.0K | $1.5M | $1.2M | $771.0K | $603.0K | $565.0K | $322.0K |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K |
| Retained earnings | -$141.8M | -$143.0M | -$143.1M | -$143.2M | -$143.5M | -$143.8M | -$144.3M | -$144.7M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $681.0K | -$1.7M | $185.0K | $99.0K | $994.0K | $322.0K | $1.3M | -$623.0K |
| Investing cash flow | — | — | $0 | — | — | — | $0 | $0 |
| Financing cash flow | -$2.0K | $289.0K | -$1.0K | -$2.0K | -$1.0K | -$1.0K | -$1.0K | $0 |
| Free cash flow | — | — | — | — | — | — | $1.3M | -$623.0K |
| Capital expenditures | — | — | — | — | — | — | $0 | $0 |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $61.0K | $60.0K | $79.0K | $70.0K | $71.0K | $76.0K | $62.0K | $65.0K |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | $577.0K | $1.1M | -$247.0K | $621.0K | -$637.0K | $896.0K | $90.0K | -$187.0K |
| Change in inventory | $939.0K | $398.0K | $506.0K | $516.0K | $318.0K | -$655.0K | -$436.0K | $330.0K |
| Change in accounts payable | $499.0K | $562.0K | -$29.0K | $312.0K | $81.0K | -$105.0K | $257.0K | -$766.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $18.8M | $14.2M | $14.2M | $10.0M | $10.2M |
| Gross profit | $11.6M | $8.7M | $8.4M | $4.7M | $5.6M |
| Operating income | $1.1M | $6.0K | -$1.6M | -$4.3M | -$3.3M |
| Net income | $1.2M | $74.0K | -$1.6M | — | -$3.9M |
| EPS (diluted) | $0.11 | $0.01 | $-0.15 | $-0.73 | — |
| EPS (basic) | $0.11 | $0.01 | $-0.15 | $-0.73 | $-0.41 |
| Operating margin | $6 | $0 | -$11 | -$43 | -$32 |
| Net margin | $6 | $1 | -$11 | — | -$38 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $13.6M | $11.2M | $11.9M | $11.0M | $17.6M |
| Total liabilities | $3.4M | $2.6M | $3.5M | $2.1M | $2.9M |
| Stockholders' equity | — | — | $8.4M | $5.6M | $11.7M |
| Total current assets | $11.2M | $8.3M | $8.4M | $8.3M | $13.6M |
| Total current liabilities | $2.8M | $1.6M | $2.1M | $1.4M | $2.4M |
| Cash & equivalents | $5.4M | $3.8M | $4.3M | $3.6M | $7.0M |
| Accounts receivable | $2.4M | $1.8M | $1.5M | $1.3M | $1.6M |
| Inventory | $3.2M | $2.6M | $2.5M | $3.2M | $4.5M |
| Other current assets | — | — | — | — | — |
| Property, plant & equipment | $106.0K | $161.0K | $152.0K | $116.0K | $72.0K |
| Goodwill | $759.0K | $759.0K | $759.0K | $759.0K | $759.0K |
| Intangible assets | $318.0K | $349.0K | $381.0K | $423.0K | $465.0K |
| Other non-current assets | $50.0K | $50.0K | $86.0K | $54.0K | $84.0K |
| Accounts payable | $914.0K | $649.0K | $873.0K | $740.0K | $1.3M |
| Accrued liabilities | $1.5M | $565.0K | $794.0K | $285.0K | $444.0K |
| Deferred revenue (current) | — | — | — | — | — |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | $71.0K | $343.0K |
| Common stock & paid-in capital | $11.0K | $11.0K | $10.0K | $10.0K | $10.0K |
| Retained earnings | -$143.1M | -$144.3M | -$144.4M | -$142.8M | -$135.7M |
| Accumulated other comprehensive income (loss) | — | — | — | — | $64.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $1.6M | -$492.0K | $827.0K | -$3.2M | -$1.4M |
| Investing cash flow | $0 | -$50.0K | -$75.0K | -$137.0K | -$85.0K |
| Financing cash flow | -$5.0K | -$5.0K | -$79.0K | $34.0K | $237.0K |
| Free cash flow | — | -$547.0K | $752.0K | -$3.4M | -$1.5M |
| Capital expenditures | — | $55.0K | $75.0K | $137.0K | $36.0K |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $296.0K | $153.0K | $1.1M | $982.0K | $1.3M |
| Deferred income taxes | — | — | — | — | $0 |
| Change in accounts receivable | $633.0K | $285.0K | $221.0K | -$357.0K | $278.0K |
| Change in inventory | $685.0K | $407.0K | -$387.0K | -$765.0K | -$296.0K |
| Change in accounts payable | $259.0K | -$220.0K | $133.0K | -$593.0K | $908.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding NEPH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-03-13 to 2026-09-14
Recent transactions
- Most recent: WEXFORD CAPITAL LP (10% owner) — Other acquisition/disposition of 3,355,111 shares on 2026-09-14.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| WEXFORD CAPITAL LP | 10% owner | Other acquisition/disposition | 2026-09-14 | 3,355,111 |
| Amron Arthur H | Director | Other acquisition/disposition | 2026-09-14 | 17,749 |
| Banks Robert R. Jr. | President and CEO | Option exercise | 2026-03-23 | 120,000 |
| Krandel Judy | Chief Financial Officer | Option exercise | 2026-03-23 | 68,861 |
| Nettis Lisa Marie | Director | Grant / award | 2025-11-10 | 1,622 |
| Spandow Oliver J. | Director | Grant / award | 2025-11-10 | 8,036 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | WEXFORD CAPITAL LP | 10% owner | Other acquisition/disposition | 3,355,111 | $0.00 |
| 2026-09-14 | WEXFORD CAPITAL LP | 10% owner | Other acquisition/disposition | 22,710 | $3.95 |
| 2026-09-14 | Amron Arthur H | Director | Other acquisition/disposition | 17,749 | $0.00 |
| 2026-09-14 | Amron Arthur H | Director | Other acquisition/disposition | 2,836 | $0.00 |
| 2026-09-14 | Amron Arthur H | Director | Other acquisition/disposition | 22,710 | $3.95 |
| 2026-08-18 | WEXFORD CAPITAL LP | 10% owner | Option exercise | 812 | $3.60 |
| 2026-08-12 | Amron Arthur H | Director | Grant / award | 2,418 | $0.00 |
| 2026-05-11 | Amron Arthur H | Director | Grant / award | 3,574 | $0.00 |
| 2026-03-23 | Banks Robert R. Jr. | President and CEO | Option exercise | 120,000 | $1.44 |
| 2026-03-23 | Krandel Judy | Chief Financial Officer | Option exercise | 68,861 | $1.71 |
| 2026-03-16 | Amron Arthur H | Director | Grant / award | 3,610 | $0.00 |
| 2025-11-10 | Nettis Lisa Marie | Director | Grant / award | 1,622 | $0.00 |
| 2025-11-10 | Spandow Oliver J. | Director | Grant / award | 8,036 | $0.00 |
| 2025-11-10 | Amron Arthur H | Director | Grant / award | 5,391 | $0.00 |
| 2025-01-01 | Amron Arthur H | Director | Grant / award | 22,418 | $0.00 |
| 2025-01-01 | Spandow Oliver J. | Director | Grant / award | 33,241 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:40 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-13 | 8-K | 2026-10-13 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-12 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-06-15 | 8-K | 2026-06-12 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-05-11 | View on SEC.gov → |
| 2026-05-07 | 8-K | 2026-05-07 | View on SEC.gov → |
| 2026-05-07 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-03-27 | 8-K | 2026-03-27 | View on SEC.gov → |
Recent news
Headlines about NEPH (Nephros, Inc.). Links open the publisher — we don’t host full articles.
-
Nephron Pharmaceuticals’ CEO is out. Here’s past coverage of the company.
Yahoo Finance · 2026-10-16 -
Nephron's Lou Kennedy out as CEO in 'leadership transition’. What we know.
Yahoo Finance · 2026-10-16 -
Nephros, Inc. (NEPH) Company Profile & Facts
Yahoo! Finance Canada · 2026-10-16 -
Nephros (NEPH) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-13 -
Nephros GAAP EPS of $0.11, revenue of $6.01M
Seeking Alpha · 2026-08-07 -
Nephros, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance · 2026-08-07 -
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...
Yahoo Finance · 2026-08-07 -
Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-06
No headlines in this category right now — try “All”.